Literature DB >> 11448716

Chameleon eye position obeys Listing's law.

P S Sándor1, M A Frens, V Henn.   

Abstract

Listing's law (LL) states that 3D-eye positions lie in a plane, when they are described as single-axis rotations from the primary position. This implies that the degrees of freedom of eye movements are reduced from three to two. Various hypotheses exist, regarding the implementation of LL. These include facilitation of binocular vision, optimization of oculomotor control, and mechanical constraints in the orbit. We recorded the 3D-eye position during saccadic scanning in the chameleon, to investigate whether LL is valid in an animal with different anatomical and behavioral characteristics compared to primates. We show that in chameleons, the eye position obeys LL with a high precision. Since the anatomical arrangement of the orbit in chameleons is very different from that in primates, and binocular fused vision is virtually absent, we suggest that in the chameleon, LL mainly optimizes oculomotor control.

Entities:  

Mesh:

Year:  2001        PMID: 11448716     DOI: 10.1016/s0042-6989(01)00111-0

Source DB:  PubMed          Journal:  Vision Res        ISSN: 0042-6989            Impact factor:   1.886


  3 in total

1.  The cone photoreceptors and visual pigments of chameleons.

Authors:  James K Bowmaker; Ellis R Loew; Matthias Ott
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2005-09-29       Impact factor: 1.836

2.  Three-dimensional vestibular eye and head reflexes of the chameleon: characteristics of gain and phase and effects of eye position on orientation of ocular rotation axes during stimulation in yaw direction.

Authors:  H Haker; H Misslisch; M Ott; M A Frens; V Henn; K Hess; P S Sándor
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2003-05-29       Impact factor: 1.836

3.  Kinematics of visually-guided eye movements.

Authors:  Bernhard J M Hess; Jakob S Thomassen
Journal:  PLoS One       Date:  2014-04-21       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.